DuPont de Nemours Inc
For the period ended Mar 31, 2025. Filed May 2, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2025 · Filed May 2, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Revenue
NOTE 5 -REVENUE
Revenue Recognition
Products
Substantially all of DuPont's revenue is derived from product sales. Product sales consist of sales of DuPont's products to supply manufacturers and distributors. DuPont considers purchase orders, which in some cases are governed by master supply agreements, to be a contract with a customer. Contracts with customers are considered to be short-term when the time between order confirmation and satisfaction of the performance obligations is equal to or less than one year.
Disaggregation of Revenue
The Company disaggregates its revenue from contracts with customers by segment and business or major product line and geographic region, as the Company believes it best depicts the nature, amount, timing and uncertainty of its revenue and cash flows.
The net trade revenue table below reflects the 2025 Segment Realignment structure.
| Net Trade Revenue by Segment and Business or Major Product Line | Three Months Ended March 31, | |
|---|---|---|
| In millions | 2025 | 2024 |
| Semiconductor Technologies | $644 | $579 |
| Interconnect Solutions | 474 | 405 |
| ElectronicsCo | $1,118 | $984 |
| Healthcare & Water Technologies | $764 | $673 |
| Diversified Industrials | 1,184 | 1,274 |
| IndustrialsCo | $1,948 | $1,947 |
| Total | $3,066 | $2,931 |
| Net Trade Revenue by Geographic Region | Three Months Ended March 31, | |
|---|---|---|
| In millions | 2025 | 2024 |
| U.S. & Canada | $1,059 | $1,053 |
| EMEA 1 | 553 | 544 |
| Asia Pacific 2 | 1,333 | 1,216 |
| Latin America | 121 | 118 |
| Total | $3,066 | $2,931 |
Europe, Middle East and Africa.
Net sales attributed to China/Hong Kong, for the three months ended March 31, 2025 and 2024 were $587 million and $515 million, respectively.
Contract Balances
From time to time, the Company enters into arrangements in which it receives payments from customers based upon contractual billing schedules. The Company records accounts receivables when the right to consideration becomes unconditional. Contract liabilities primarily reflect deferred revenue from advance payment for product that the Company has received from customers. The Company classifies deferred revenue as current or noncurrent based on the timing of when the Company expects to recognize revenue.
Revenue recognized in the first three months of 2025 and 2024 from amounts included in contract liabilities at the beginning of the period was insignificant.
| Contract Balances | March 31, 2025 | December 31, 2024 |
|---|---|---|
| In millions | ||
| Accounts and notes receivable - trade 1 | $1,692 | $1,561 |
| Deferred revenue - current 2 | $5 | $2 |
| Deferred revenue - noncurrent 3 | $37 | $36 |
Included in "Accounts and notes receivable - net" in the interim Condensed Consolidated Balance Sheets.
Included in "Accrued and other current liabilities" in the interim Condensed Consolidated Balance Sheets.
Included in "Other noncurrent obligations" in the interim Condensed Consolidated Balance Sheets.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.